Condition

Down syndrome

Clinical trials and treatment information for Down syndrome

1.6M
People Affected
50
Active Trials
400K
New Cases/Year
29K
Deaths/Year

Treatment Rankings

Ranked by evidence volume first. Medicine has spent centuries ranking things by vibes. This is an improvement.

1
Thyroid Hormone Replacement (Levothyroxine) for Hypothyroidism
95% Effectivenessβ€’ 95% Confidenceβ€’ 65% Safetyβ€’ 100 trialsβ€’ 10K participants
HIGH EvidenceExcellent ValueDose: 2-6 mcg/kg/day, titrated to TSH levels
Find Trials

Comparative Safety Scale(Higher is safer)

Cyanide☠️
MethπŸ’€
Cigarettes🚬
Chemo☒️
Alcohol🍺
MorphineπŸ’Š
AntibioticsπŸ’‰
TylenolπŸ’Š
ExerciseπŸƒ
WaterπŸ’§
65
DangerousModerateSafe

Time to Effect

2-4 weeks

Duration

lifetime

Response Rate

95%

Remission Rate

%

Number Needed to Treat (NNT)

3

Number Needed to Harm (NNH)

10

Common Side Effects:

Hyperactivity (from overdose): 5%
Insomnia (from overdose): 3%
Tremors (from overdose): 2%

Annual Cost of Care

Drug Cost

$100

Monitoring

$200

Side Effects

$50

Total Annual

$350

Cost-Effectiveness

EXCELLENT

QALYs Gained

1.5

Cost per Responder

$368.42

Treatment Outcomes
Efficacy Outcomes
Overall Effectiveness
+95%
Response Rate
+95%
Common Side Effects
Hyperactivity (from overdose)
+5%
Insomnia (from overdose)
+3%
Tremors (from overdose)
+2%

Clinical Trial Phases:

Phase 4
2
Surgical Repair of Congenital Heart Defects
90% Effectivenessβ€’ 95% Confidenceβ€’ 60% Safetyβ€’ 1 trialsβ€’ 100K participants
HIGH EvidenceExcellent Value
Find Trials

Comparative Safety Scale(Higher is safer)

Cyanide☠️
MethπŸ’€
Cigarettes🚬
Chemo☒️
Alcohol🍺
MorphineπŸ’Š
AntibioticsπŸ’‰
TylenolπŸ’Š
ExerciseπŸƒ
WaterπŸ’§
60
DangerousModerateSafe

Time to Effect

immediate (post-recovery)

Duration

one-time surgery, followed by lifelong monitoring

Response Rate

90%

Remission Rate

85%

Common Side Effects:

Infection: 8%
Arrhythmias: 10%
Bleeding: 5%
Post-operative pain: 30%

Annual Cost of Care

Drug Cost

$0

Monitoring

$1,000

Side Effects

$2,000

Total Annual

$3,000

Cost-Effectiveness

EXCELLENT

QALYs Gained

10

Cost per Remission

$3,529.41

Cost per Responder

$3,333.33

Treatment Outcomes
Primary Outcomes
Systolic Pulmonary Artery Pressure60 mmHg
-50% (-30 mmHg)
Peripheral Oxygen Saturation (SpO2)85%
+14.1% (+12%)
Left Ventricular Ejection Fraction55%
+12.7% (+7%)
NT-proBNP Level500 pg/mL
-60% (-300 pg/mL)
Secondary Benefits
Weight-for-Age Z-score-1.5
+66.7% (+1.0)
Annual Episodes of Lower Respiratory Tract Infection4 episodes/year
-75% (-3 episodes/year)
Vineland Adaptive Behavior Scales (VABS) Daily Living Skills Score60/100
+13.3% (+8 points)
Common Side Effects
Infection
+8%
Arrhythmias
+10%
Bleeding
+5%

Clinical Trial Phases:

Phase 4
3
Early Intervention Programs (Comprehensive Developmental Therapies)
85% Effectivenessβ€’ 90% Confidenceβ€’ 95% Safetyβ€’ 500 trialsβ€’ 50K participants
MODERATE EvidenceGood ValueDose: 5-15 hours/week of structured therapy/support
Find Trials

Comparative Safety Scale(Higher is safer)

Cyanide☠️
MethπŸ’€
Cigarettes🚬
Chemo☒️
Alcohol🍺
MorphineπŸ’Š
AntibioticsπŸ’‰
TylenolπŸ’Š
ExerciseπŸƒ
WaterπŸ’§
95
DangerousModerateSafe

Time to Effect

3-6 months

Duration

lifetime (varying intensity)

Response Rate

80%

Remission Rate

%

Common Side Effects:

Fatigue: 5%
Temporary frustration: 3%

Annual Cost of Care

Drug Cost

$0

Monitoring

$500

Side Effects

$0

Total Annual

$500

Cost-Effectiveness

GOOD

QALYs Gained

1

Cost per Responder

$18,750

Treatment Outcomes
Efficacy Outcomes
Overall Effectiveness
+85%
Response Rate
+80%
Common Side Effects
Fatigue
+5%
Temporary frustration
+3%

Clinical Trial Phases:

Phase 4
4
Special Education Services
80% Effectivenessβ€’ 85% Confidenceβ€’ 95% Safetyβ€’ 300 trialsβ€’ 100K participants
MODERATE EvidenceGood ValueDose: 20-30 hours/week of specialized instruction/support
Find Trials

Comparative Safety Scale(Higher is safer)

Cyanide☠️
MethπŸ’€
Cigarettes🚬
Chemo☒️
Alcohol🍺
MorphineπŸ’Š
AntibioticsπŸ’‰
TylenolπŸ’Š
ExerciseπŸƒ
WaterπŸ’§
95
DangerousModerateSafe

Time to Effect

6-12 months

Duration

childhood through young adulthood

Response Rate

75%

Remission Rate

%

Common Side Effects:

Frustration with learning: 5%
Social stigma: 2%

Annual Cost of Care

Drug Cost

$0

Monitoring

$500

Side Effects

$0

Total Annual

$500

Cost-Effectiveness

GOOD

QALYs Gained

1

Cost per Responder

$24,000

Treatment Outcomes
Efficacy Outcomes
Overall Effectiveness
+80%
Response Rate
+75%
Common Side Effects
Frustration with learning
+5%
Social stigma
+2%

Clinical Trial Phases:

Phase 4
5
Speech-Language Therapy
75% Effectivenessβ€’ 85% Confidenceβ€’ 95% Safetyβ€’ 5 trialsβ€’ 20K participants
MODERATE EvidenceGood ValueDose: 1-3 sessions/week (30-60 min/session)
Find Trials

Comparative Safety Scale(Higher is safer)

Cyanide☠️
MethπŸ’€
Cigarettes🚬
Chemo☒️
Alcohol🍺
MorphineπŸ’Š
AntibioticsπŸ’‰
TylenolπŸ’Š
ExerciseπŸƒ
WaterπŸ’§
95
DangerousModerateSafe

Time to Effect

3-6 months

Duration

long-term (varying intensity)

Response Rate

70%

Remission Rate

%

Common Side Effects:

Fatigue: 3%
Frustration: 2%

Annual Cost of Care

Drug Cost

$0

Monitoring

$500

Side Effects

$0

Total Annual

$500

Cost-Effectiveness

GOOD

QALYs Gained

0.5

Cost per Responder

$7,142.86

Treatment Outcomes
Primary Outcomes
Speech Intelligibility30% intelligible (to unfamiliar listeners)
+50% (+15% (absolute increase))
Expressive Vocabulary Standard Score60 points (on a standardized test, mean=100, SD=15)
+16.67% (+10 points)
Mean Length of Utterance (MLU) in morphemes1.5 morphemes
+40% (+0.6 morphemes)
Receptive Language Standard Score65 points (on a standardized test, mean=100, SD=15)
+12.31% (+8 points)
Secondary Benefits
Social Communication Skills Standard Score70 points (on a parent-report scale, mean=100, SD=15)
+10% (+7 points)
Functional Communication Independent Acts5 independent communicative acts per hour
+60% (+3 independent communicative acts per hour)
Parental Stress (Communication-Related) Scale Score30 points (on a 0-60 scale, higher is more stress)
-23.33% (-7 points)
Common Side Effects
Fatigue
+3%
Frustration
+2%

Clinical Trial Phases:

Phase 4
6
Physical Therapy
70% Effectivenessβ€’ 80% Confidenceβ€’ 95% Safetyβ€’ 55 trialsβ€’ 15K participants
MODERATE EvidenceGood ValueDose: 1-2 sessions/week (30-60 min/session)
Find Trials

Comparative Safety Scale(Higher is safer)

Cyanide☠️
MethπŸ’€
Cigarettes🚬
Chemo☒️
Alcohol🍺
MorphineπŸ’Š
AntibioticsπŸ’‰
TylenolπŸ’Š
ExerciseπŸƒ
WaterπŸ’§
95
DangerousModerateSafe

Time to Effect

3-6 months

Duration

long-term (varying intensity)

Response Rate

65%

Remission Rate

%

Common Side Effects:

Muscle soreness: 5%
Fatigue: 4%

Annual Cost of Care

Drug Cost

$0

Monitoring

$500

Side Effects

$0

Total Annual

$500

Cost-Effectiveness

GOOD

QALYs Gained

0.4

Cost per Responder

$6,153.85

Treatment Outcomes
Primary Outcomes
Gross Motor Function Measure (GMFM-88) Total Score65% of max score (for toddlers/preschoolers with Down syndrome)
+12% (+7.8 percentage points)
Peabody Developmental Motor Scales-2 (PDMS-2) Gross Motor Quotient (GMQ)60 points (age-equivalent for young children with Down syndrome)
+10% (+6 points)
Pediatric Balance Scale (PBS) Score45/56 points (for school-aged children with Down syndrome)
+8% (+3.6 points)
Secondary Benefits
Pediatric Quality of Life Inventory (PedsQL) - Physical Functioning Scale Score (Parent Proxy)60/100 points (for children with Down syndrome)
+10% (+6 points)
6-Minute Walk Test (6MWT) Distance250 meters (for adolescents/adults with Down syndrome)
+15% (+37.5 meters)
Adaptive Behavior Assessment System-3 (ABAS-3) - Motor Domain Standard Score65 points (low average for functional motor skills in individuals with Down syndrome)
+8% (+5.2 points)
Common Side Effects
Muscle soreness
+5%
Fatigue
+4%

Clinical Trial Phases:

Phase 4
7
Occupational Therapy
70% Effectivenessβ€’ 80% Confidenceβ€’ 95% Safetyβ€’ 1 trialsβ€’ 15K participants
MODERATE EvidenceGood ValueDose: 1-2 sessions/week (30-60 min/session)
Find Trials

Comparative Safety Scale(Higher is safer)

Cyanide☠️
MethπŸ’€
Cigarettes🚬
Chemo☒️
Alcohol🍺
MorphineπŸ’Š
AntibioticsπŸ’‰
TylenolπŸ’Š
ExerciseπŸƒ
WaterπŸ’§
95
DangerousModerateSafe

Time to Effect

3-6 months

Duration

long-term (varying intensity)

Response Rate

65%

Remission Rate

%

Common Side Effects:

Frustration: 3%
Fatigue: 2%

Annual Cost of Care

Drug Cost

$0

Monitoring

$500

Side Effects

$0

Total Annual

$500

Cost-Effectiveness

GOOD

QALYs Gained

0.4

Cost per Responder

$6,153.85

Treatment Outcomes
Primary Outcomes
Adaptive Behavior (Daily Living Skills)Vineland Adaptive Behavior Scales (VABS-3), Daily Living Skills domain: 65 (standard score)
+7.7% (+5 standard score points)
Fine Motor SkillsBruininks-Oseretsky Test of Motor Proficiency (BOT-2), Fine Motor Control composite: 35 (standard score)
+14.3% (+5 standard score points)
Gross Motor SkillsBruininks-Oseretsky Test of Motor Proficiency (BOT-2), Gross Motor Composite: 38 (standard score)
+13.2% (+5 standard score points)
Participation in Play/School ActivitiesPediatric Evaluation of Disability Inventory - Computer Adaptive Test (PEDI-CAT), Participation domain: 20 (scaled score)
+25% (+5 scaled score points)
Secondary Benefits
Caregiver Assistance Required for Daily TasksPediatric Evaluation of Disability Inventory (PEDI), Self-Care Functional Skills score: 25/100 (lower score indicates more assistance needed)
+40% (+10 points on PEDI Functional Skills score)
Social ParticipationPediatric Evaluation of Disability Inventory - Computer Adaptive Test (PEDI-CAT), Social/Cognitive domain: 22 (scaled score)
+22.7% (+5 scaled score points)
Sensory Processing DifficultiesSensory Profile 2, Overall Sensory Processing Score: 70 (higher score indicates more difficulties)
-7.1% (-5 standard score points)
Common Side Effects
Frustration
+3%
Fatigue
+2%

Clinical Trial Phases:

Phase 4